In a very review in breast most cancers cells, The mix of lapatinib, a twin HER2/neu and EGFR tyrosine kinase inhibitor, with INK128 prevented both HER2 and HER3 phosphorylation induced by INK128 and created synergistic induction of cell death in numerous HER2-optimistic cell lines resistant to trastuzumab and lapatinib. In https://johno529ejn2.blogdosaga.com/profile